IMP
Process View
positive regulation of adherens junction organization
Any process that activates or increases the frequency, rate or extent of adherens junction organization.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of adherens junction organization"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 1.000 | Human | |
| S100A6 | S100 calcium binding protein A6 | 1.000 | Human | |
| S100A9 | S100 calcium binding protein A9 | 0.987 | Human | |
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.986 | Human | |
| VEGFA | vascular endothelial growth factor A | 0.985 | ||
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.936 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.936 | Human | |
| S100A8 | S100 calcium binding protein A8 | 0.907 | Human | |
| EGFR | epidermal growth factor receptor | 0.756 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.601 | Human | |
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.563 | Human | |
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.549 | ||
| S100A4 | S100 calcium binding protein A4 | 0.513 | Human | |
| PLCG1 | phospholipase C, gamma 1 | 0.502 | ||
| ANGPT2 | angiopoietin 2 | 0.453 | ||
| S100A11 | S100 calcium binding protein A11 | 0.452 | Human | |
| S100B | S100 calcium binding protein B | 0.446 | Human | |
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.381 | Human | |
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.358 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.321 | ||
| S100A1 | S100 calcium binding protein A1 | 0.254 | Human | |
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.243 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.220 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.218 | ||
| PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.216 | ||
| ANXA2 | annexin A2 | 0.209 | ||
| LPXN | leupaxin | 0.182 | Human | |
| TSG101 | tumor susceptibility gene 101 | 0.165 | ||
| LIMS1 | LIM and senescent cell antigen-like domains 1 | 0.149 | ||
| PHC2 | polyhomeotic homolog 2 (Drosophila) | 0.124 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.122 | ||
| NRP1 | neuropilin 1 | 0.121 | ||
| PGF | placental growth factor | 0.108 | Human | |
| ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.103 | ||
| TSC2 | tuberous sclerosis 2 | 0.092 | ||
| ANGPT1 | angiopoietin 1 | 0.079 | ||
| LAT | linker for activation of T cells | 0.078 | ||
| KITLG | KIT ligand | 0.076 | ||
| DPYSL4 | dihydropyrimidinase-like 4 | 0.073 | ||
| GHR | growth hormone receptor | 0.067 | ||
| LGALS3 | lectin, galactoside-binding, soluble, 3 | 0.053 | ||
| FKBP4 | FK506 binding protein 4, 59kDa | 0.053 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.052 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.050 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.050 | Human | |
| ITGA7 | integrin, alpha 7 | 0.047 | ||
| FEM1B | fem-1 homolog b (C. elegans) | 0.045 | ||
| SH3GL3 | SH3-domain GRB2-like 3 | 0.042 | ||
| NCK2 | NCK adaptor protein 2 | 0.039 | ||
| HOXA1 | homeobox A1 | 0.036 | ||
| EMP3 | epithelial membrane protein 3 | 0.035 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.035 | ||
| SMAD2 | SMAD family member 2 | 0.034 | ||
| S100A10 | S100 calcium binding protein A10 | 0.033 | ||
| PLP2 | proteolipid protein 2 (colonic epithelium-enriched) | 0.028 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.028 | ||
| RHOA | ras homolog gene family, member A | 0.026 | ||
| TMSB10 | thymosin beta 10 | 0.026 | ||
| LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.025 | ||
| AGER | advanced glycosylation end product-specific receptor | 0.024 | ||
| S100P | S100 calcium binding protein P | 0.024 | Human | |
| IGF1R | insulin-like growth factor 1 receptor | 0.023 | ||
| PDGFC | platelet derived growth factor C | 0.023 | ||
| ILK | integrin-linked kinase | 0.021 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.021 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.020 | ||
| DPPA4 | developmental pluripotency associated 4 | 0.020 | ||
| S100A2 | S100 calcium binding protein A2 | 0.020 | Human | |
| TRIP6 | thyroid hormone receptor interactor 6 | 0.020 | ||
| FHL2 | four and a half LIM domains 2 | 0.018 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.018 | ||
| AREG | amphiregulin | 0.017 | ||
| S100A12 | S100 calcium binding protein A12 | 0.016 | Human | |
| TEK | TEK tyrosine kinase, endothelial | 0.016 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.016 | ||
| PHF21A | PHD finger protein 21A | 0.015 | ||
| SH3GL2 | SH3-domain GRB2-like 2 | 0.014 | ||
| CDC42EP3 | CDC42 effector protein (Rho GTPase binding) 3 | 0.014 | ||
| GIPC1 | GIPC PDZ domain containing family, member 1 | 0.013 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.012 | ||
| PARVA | parvin, alpha | 0.012 | ||
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.012 | Human | |
| CHMP4B | chromatin modifying protein 4B | 0.011 | ||
| CSTA | cystatin A (stefin A) | 0.011 | ||
| ZNF331 | zinc finger protein 331 | 0.011 | ||
| LDLR | low density lipoprotein receptor | 0.010 | ||
| GPR116 | G protein-coupled receptor 116 | 0.010 |